Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,763 | 262 | 99.7% |
| Entertainment | $12.78 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $973.06 | 77 | $0 (2024) |
| GlaxoSmithKline, LLC. | $359.02 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $320.12 | 23 | $0 (2024) |
| PFIZER INC. | $184.02 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $182.25 | 12 | $0 (2023) |
| ABBVIE INC. | $153.25 | 10 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $140.43 | 11 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $139.60 | 10 | $0 (2024) |
| Allergan, Inc. | $125.92 | 10 | $0 (2020) |
| IDORSIA PHARMACEUTICALS US INC | $103.12 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $519.07 | 33 | Novo Nordisk Inc ($183.49) |
| 2023 | $445.89 | 28 | Novo Nordisk Inc ($149.45) |
| 2022 | $558.49 | 38 | Novo Nordisk Inc ($169.67) |
| 2021 | $457.69 | 27 | GlaxoSmithKline, LLC. ($82.61) |
| 2020 | $471.44 | 32 | Novo Nordisk Inc ($89.56) |
| 2019 | $406.68 | 35 | Novo Nordisk Inc ($162.27) |
| 2018 | $514.74 | 41 | Novo Nordisk Inc ($123.08) |
| 2017 | $401.33 | 29 | AstraZeneca Pharmaceuticals LP ($62.89) |
All Payment Transactions
263 individual payment records from CMS Open Payments — Page 3 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/13/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Diabetes | ||||||
| 04/10/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: INSOMNIA | ||||||
| 03/15/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: Diabetes | ||||||
| 03/02/2023 | Corium, LLC | Adlarity (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 02/16/2023 | Merck Sharp & Dohme LLC | PNEUMOVAX 23 (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: VACCINE | ||||||
| 02/09/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Obesity | ||||||
| 02/07/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Diabetes | ||||||
| 01/26/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: INSOMNIA | ||||||
| 01/19/2023 | Corium, LLC | Adlarity (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 12/21/2022 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Diabetes | ||||||
| 12/15/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/08/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Diabetes | ||||||
| 12/08/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.87 | General |
| Category: Diabetes | ||||||
| 11/30/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Diabetes | ||||||
| 11/17/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Diabetes | ||||||
| 11/16/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: INSOMNIA | ||||||
| 11/09/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/02/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/27/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Diabetes | ||||||
| 10/07/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: Diabetes | ||||||
| 10/05/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PROQUAD, VAXNEUVANCE | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: VACCINE | ||||||
| 09/14/2022 | Corium, LLC | ADLARITY (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Treatment of dementia of the Alzheimers type | ||||||
| 09/09/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 57 | 3,784 | 12,511 | $562,820 | $168,299 |
| 2022 | 59 | 3,946 | 11,406 | $584,679 | $176,732 |
| 2021 | 58 | 3,912 | 11,814 | $573,388 | $179,824 |
| 2020 | 54 | 4,105 | 12,528 | $586,829 | $169,648 |
All Medicare Procedures & Services
228 procedure records from CMS Medicare Utilization — Page 2 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 71046 | X-ray of chest, 2 views | Office | 2023 | 63 | 73 | $5,475 | $952.44 | 17.4% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 14 | 14 | $12,740 | $938.47 | 7.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 55 | 63 | $4,158 | $931.14 | 22.4% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 22 | 22 | $6,534 | $921.74 | 14.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 79 | 158 | $3,160 | $894.28 | 28.3% |
| 77065 | Diagnostic mammography of 1 breast | Office | 2023 | 16 | 16 | $5,360 | $805.35 | 15.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 40 | 40 | $2,480 | $756.80 | 30.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 19 | 19 | $2,090 | $657.78 | 31.5% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 53 | 5,890 | $5,890 | $628.07 | 10.7% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 11 | 11 | $3,135 | $553.26 | 17.6% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 18 | 18 | $720.00 | $494.91 | 68.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $560.00 | $455.04 | 81.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 37 | 52 | $1,924 | $431.08 | 22.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 18 | 20 | $1,240 | $360.40 | 29.1% |
| 76642 | Limited ultrasound scan of 1 breast | Office | 2023 | 12 | 13 | $2,600 | $353.02 | 13.6% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 17 | 17 | $1,496 | $340.64 | 22.8% |
| 82746 | Folic acid level, serum | Office | 2023 | 19 | 20 | $1,320 | $288.20 | 21.8% |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | Office | 2023 | 16 | 261 | $1,305 | $282.03 | 21.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 26 | 31 | $1,550 | $274.04 | 17.7% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 12 | 15 | $1,230 | $235.13 | 19.1% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 12 | 13 | $975.00 | $220.43 | 22.6% |
| 83540 | Iron level | Office | 2023 | 24 | 33 | $759.00 | $202.88 | 26.7% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 14 | 16 | $720.00 | $187.50 | 26.0% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 11 | 11 | $385.00 | $178.20 | 46.3% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 12 | 12 | $624.00 | $146.96 | 23.6% |
About Dr. Eric Delay, M.D
Dr. Eric Delay, M.D is a Pediatrics healthcare provider based in Morristown, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366460412.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Delay, M.D has received a total of $3,775 in payments from pharmaceutical and medical device companies, with $519.07 received in 2024. These payments were reported across 263 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($3,763).
As a Medicare-enrolled provider, Delay has provided services to 15,747 Medicare beneficiaries, totaling 48,259 services with total Medicare billing of $694,503. Data is available for 4 years (2020–2023), covering 228 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Morristown, TN
- Active Since 07/17/2006
- Last Updated 02/08/2024
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1366460412
Products in Payments
- Ozempic (Drug) $489.53
- FARXIGA (Drug) $196.57
- Rybelsus (Drug) $175.97
- JARDIANCE (Drug) $152.33
- TRELEGY ELLIPTA (Drug) $119.11
- SHINGRIX (Biological) $113.78
- Tresiba (Drug) $111.34
- UBRELVY (Drug) $105.49
- QUVIVIQ (Drug) $103.12
- Victoza (Drug) $98.78
- XARELTO (Drug) $96.54
- ENTRESTO (Drug) $96.02
- Trintellix (Drug) $78.15
- NURTEC ODT (Drug) $72.83
- Vascepa (Drug) $72.43
- Wegovy (Drug) $69.06
- TOUJEO (Drug) $61.23
- Adlarity (Drug) $59.90
- TRULICITY (Drug) $56.79
- NEXLETOL (Drug) $55.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Morristown
Dr. Simona Nativ, Md, MD
Pediatrics — Payments: $7,707
Kanika Shanker, Md, MD
Pediatrics — Payments: $5,970
Mrs. Kristin Sabanosh, Rn Msn Cpnp, RN MSN CPNP
Pediatrics — Payments: $5,099
Dr. Tamara Mccluskey, Do, DO
Pediatrics — Payments: $3,387
Stephanie Schuckalo, Apn, APN
Pediatrics — Payments: $3,183
Dr. Gwyn Poblete, Md, MD
Pediatrics — Payments: $2,988